AUTOWEB, INC. Inducement Stock Option Award Agreement (Non-Qualified Stock Options)Inducement Stock Option Award Agreement • March 7th, 2019 • AutoWeb, Inc. • Services-computer programming, data processing, etc. • Delaware
This Inducement Stock Option Award Agreement (“Agreement”) is entered into effective as of the Grant Date set forth on the signature page to this Agreement (“Grant Date”) by and between AutoWeb, Inc., a Delaware corporation (“Company”), and the person set forth as Participant on the signature page hereto (“Participant”).
AUTOWEB, INC. Inducement Stock Option Award Agreement (Non-Qualified Stock Options)Inducement Stock Option Award Agreement • March 24th, 2022 • AutoWeb, Inc. • Services-computer programming, data processing, etc. • Delaware
This Inducement Stock Option Award Agreement (“Agreement”) is entered into effective as of the Grant Date set forth on the signature page to this Agreement (“Grant Date”) by and between AutoWeb, Inc., a Delaware corporation (“Company”), and the person set forth as Optionee on the signature page hereto (“Optionee”).
Inducement Stock Option Award Agreement (Non-Qualified Performance-Based Stock Options)Inducement Stock Option Award Agreement • November 7th, 2013 • Autobytel Inc • Services-computer programming, data processing, etc. • Delaware
This Inducement Stock Option Award Agreement ("Agreement") is entered into effective as of the Grant Date set forth on the signature page to this Agreement ("Grant Date") by and between Autobytel Inc., a Delaware corporation ("Company"), and the person set forth as Optionee on the signature page hereto ("Optionee").
To: Douglas Allen Pertz From: McAlister C. Marshall, II Date: June 9, 2016 Subject: Inducement Stock Option Award AgreementInducement Stock Option Award Agreement • July 28th, 2016 • Brinks Co • Arrangement of transportation of freight & cargo • Texas
On June 9, 2016 (the “Grant Date”), the Compensation and Benefits Committee of the Board of Directors of The Brink’s Company (the “Company”), in accordance with the terms of The Brink’s Company 2013 Equity Incentive Plan (the “Plan”), granted you this award (this “Award”) of nonqualified stock options (the “Options”) to purchase 400,000 shares of common stock of the Company (each, a “Share”) at a price of $29.87 per Share. Capitalized terms that are used but not defined herein or in the Terms and Conditions attached hereto (collectively, this “Award Agreement”) shall have the meanings ascribed to such terms in the Plan. For purposes of this Award Agreement, the terms “Cause”, “Good Reason” and “Incapacity” shall have the meanings ascribed to such terms in the Offer Letter, dated as of June 9, 2016, between the Company and you (the “Offer Letter”).
Inducement Stock Option Award AgreementInducement Stock Option Award Agreement • September 17th, 2008 • Neurobiological Technologies Inc /Ca/ • Biological products, (no disgnostic substances) • California
AUTOWEB, INC. Inducement Stock Option Award Agreement (Non-Qualified Stock Options)Inducement Stock Option Award Agreement • April 18th, 2018 • AutoWeb, Inc. • Services-computer programming, data processing, etc. • Delaware
This Inducement Stock Option Award Agreement (“Agreement”) is entered into effective as of the Grant Date set forth on the signature page to this Agreement (“Grant Date”) by and between AutoWeb, Inc., a Delaware corporation (“Company”), and the person set forth as Optionee on the signature page hereto (“Optionee”).
AUTOBYTEL INC. Inducement Stock Option Award Agreement (Non-Qualified Stock Options)Inducement Stock Option Award Agreement • August 6th, 2015 • Autobytel Inc • Services-computer programming, data processing, etc. • Delaware
This Inducement Stock Option Award Agreement (“Agreement”) is entered into effective as of the Grant Date set forth on the signature page to this Agreement (“Grant Date”) by and between Autobytel Inc., a Delaware corporation (“Company”), and the person set forth as Optionee on the signature page hereto (“Optionee”).
SAREPTA THERAPEUTICS, INC. EXECUTIVE INDUCEMENT STOCK OPTION AWARD AGREEMENTInducement Stock Option Award Agreement • March 3rd, 2014 • Sarepta Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Unless otherwise defined herein, capitalized terms used in this executive inducement stock option agreement and the exhibits hereto (the “Award Agreement”) shall have the definitions for such terms included in Exhibit B hereto.
INDUCEMENT STOCK OPTION AWARD AGREEMENTInducement Stock Option Award Agreement • May 14th, 2018 • InfuSystem Holdings, Inc • Surgical & medical instruments & apparatus
THIS INDUCEMENT STOCK OPTION AGREEMENT (the “Agreement”), made as of May 7, 2018 (the “Grant Date”), by and between InfuSystem Holdings, Inc. (the “Company”) and Gregory Schulte (“Optionee”).
Inducement Stock Option Award Agreement (Non-Qualified Performance-Based Stock Options)Inducement Stock Option Award Agreement • February 20th, 2014 • Autobytel Inc • Services-computer programming, data processing, etc. • Delaware
This Inducement Stock Option Award Agreement ("Agreement") is entered into effective as of the Grant Date set forth on the signature page to this Agreement ("Grant Date") by and between Autobytel Inc., a Delaware corporation ("Company"), and the person set forth as Optionee on the signature page hereto ("Optionee").
INDUCEMENT STOCK OPTION AWARD AGREEMENTInducement Stock Option Award Agreement • September 5th, 2023 • FreightCar America, Inc. • Railroad equipment • Delaware
THIS INDUCEMENT STOCK OPTION AWARD AGREEMENT (this “Agreement”) is made and entered into as of June 26, 2023 (the “Date of Grant”) by and between FreightCar America, Inc., a Delaware corporation (the “Company”), and Nicholas J. Randall (the “Option Holder”).
INDUCEMENT STOCK OPTION AWARD AGREEMENT (Non-Plan Inducement Award)Inducement Stock Option Award Agreement • November 5th, 2020 • Ani Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS INDUCEMENT STOCK OPTION AWARD AGREEMENT (this “Agreement”) is entered into and effective as of this 8th day of September, 2020 (the “Date of Grant”), by and between ANI Pharmaceuticals, Inc. (the “Company”) and Nikhil Lalwani (the “Optionee”).
